Skip to main content
    O

    Organon & Co (OGN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $13.91
    +0.01 (+0.07%)

    Market Cap: $3.65B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Organon & Co (OGN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Organon are Grifols SA ADR (GRFS), Ionis Pharmaceuticals (IONS) and Progyny (PGNY). Organon trades at 4.6x earnings, against a median of 27.3x for the 8 of these companies with a P/E. By market cap, Organon ranks 9th of the 13 companies on this page; Johnson & Johnson (JNJ) is the largest at $687.89B.

    Peer Comparison

    OGN's ROIC of 6.2% is below the peer median of 7.3%, and its revenue growth of -1.7% is below the median of 9.2%. It yields 0.58%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Organon (OGN)$3.65B4.6x0.6x3.5%6.2%-1.7%0.58%
    Grifols SA ADR (GRFS)$5.91B9.9x0.7x6.4%7.6%9.4%1.08%
    Ionis Pharmaceuticals Inc (IONS)$4.84BN/A4.8x-56.9%-29.3%54.9%0.00%
    Progyny Inc (PGNY)$2.66B28.0x2.1x6.8%N/A8.9%0.00%
    Merck & Company Inc (MRK)$364.26B46.3x5.3x3.6%3.1%4.7%2.35%
    Amgen Inc (AMGN)$251.89B19.9x6.4x24.1%17.0%8.5%2.18%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Novo Nordisk A/S (NVO)$183.52BN/A3.6x33.9%34.1%5.6%4.32%
    Biogen Inc (BIIB)$37.46B21.4x3.6x3.4%1.3%10.6%0.00%
    TransMedics Group Inc (TMDX)$3.17B70.9x4.4x19.9%7.0%41.1%0.00%
    Xenon Pharmaceuticals Inc (XENE)$3.98BN/AN/A0.0%N/A-100.0%0.00%
    Iovance Biotherapeutics Inc (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Johnson & Johnson (JNJ)$687.89B26.6x6.9x16.2%12.8%5.9%1.90%
    Peer median$5.38B27.3x4.4x5.0%7.3%9.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Organon, ranked by how closely their business, size, sector and industry match. The largest group, 6 of the 12, is in Drug Manufacturers - General; the other 6 span 3 industries.

    CompanyAboutPeers
    Grifols SA ADR (GRFS)Drug Manufacturers - General
    Grifols, SA is dedicated to obtaining, manufacturing, preparing and selling therapeutic products, mainly blood derivatives.
    GRFS competitors
    Ionis Pharmaceuticals Inc (IONS)Biotechnology
    Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
    IONS competitors
    Progyny Inc (PGNY)Healthcare Plans
    Progyny, Inc., a benefits management company, specializes in fertility benefits and family development solutions for employers in the United States.
    PGNY competitors
    Merck & Company Inc (MRK)Drug Manufacturers - General
    Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey.
    MRK competitors
    Amgen Inc (AMGN)Drug Manufacturers - General
    Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
    AMGN competitors
    Legend Biotech Corp (LEGN)Biotechnology
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Novo Nordisk A/S (NVO)Drug Manufacturers - General
    Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally.
    NVO competitors
    Biogen Inc (BIIB)Drug Manufacturers - General
    Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development...
    BIIB competitors
    TransMedics Group Inc (TMDX)Medical Devices
    TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ...
    TMDX competitors
    Xenon Pharmaceuticals Inc (XENE)Biotechnology
    Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders...
    XENE competitors
    Iovance Biotherapeutics Inc (IOVA)Biotechnology
    Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness...
    IOVA competitors
    Johnson & Johnson (JNJ)Drug Manufacturers - General
    Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
    JNJ competitors

    Frequently Asked Questions About OGN

    Who are Organon's main competitors?

    The companies most similar to Organon include Grifols SA ADR (GRFS), Ionis Pharmaceuticals (IONS), Progyny (PGNY), Merck & Company (MRK) and Amgen (AMGN), listed from the closest match.

    Who is Organon's biggest competitor?

    Johnson & Johnson (JNJ) is the largest of the similar companies at $687.89B; Grifols SA ADR (GRFS) is the closest match by business profile, size, sector and industry.

    How does OGN stock compare with its competitors?

    OGN's P/E is 4.6x against a peer median of 27.3x; its P/S is 0.6x against a peer median of 4.4x; its net margin is 3.5% against a peer median of 5.0%.

    Which of Organon's competitors pays a higher dividend?

    Organon has a forward dividend yield of 0.58%. Novo Nordisk A/S (NVO), Merck & Company (MRK), Amgen (AMGN), Johnson & Johnson (JNJ) and Grifols SA ADR (GRFS) have higher forward dividend yields; Novo Nordisk A/S (NVO) has the highest at 4.32%.

    Is Organon bigger than its competitors?

    No. Organon is 9th by market cap among the 13 companies on this page; the largest is Johnson & Johnson (JNJ) at $687.89B.